Sphingosine 1-phosphate Receptor Modulator [EPC]

13876 reported adverse events

Drugs of this class: PONESIMOD FINGOLIMOD SIPONIMOD

These side effects are most commonly reported by patients taking drugs of the Sphingosine 1-phosphate Receptor Modulator [EPC] class:

# Side effect Count
0 FATIGUE 1248
1 HEADACHE 1073
2 MULTIPLE SCLEROSIS RELAPSE 1068
3 DIZZINESS 816
4 MULTIPLE SCLEROSIS 772
5 LYMPHOPENIA 685
6 DRUG INEFFECTIVE 681
7 GAIT DISTURBANCE 637
8 FALL 607
9 LYMPHOCYTE COUNT DECREASED 576
See all common reactions for Sphingosine 1-phosphate Receptor Modulator [EPC]

Drugs of the Sphingosine 1-phosphate Receptor Modulator [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GAIT SPASTIC 54 0.1574
1 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 170 0.1362
2 RELAPSING-REMITTING MULTIPLE SCLEROSIS 107 0.1238
3 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 94 0.0500
4 LYMPHOPENIA 685 0.0484
5 MENINGITIS CRYPTOCOCCAL 73 0.0417
6 CRYPTOCOCCOSIS 55 0.0337
7 LYMPHOCYTE COUNT DECREASED 576 0.0326
8 VACCINATION FAILURE 46 0.0276
9 MONOPARESIS 49 0.0271
See all enriched reactions for Sphingosine 1-phosphate Receptor Modulator [EPC]